Clinical Trials for Endometrial Cancer
GY025
A Randomized Phase III Trial of Nivoluman and Ipilimumab Compared to Nivolumab Monotherapy in Patients with Deficient Mismatch Repair System Recurrent Endometrial Carcinoma. View details.
- Research
- Clinical Trials at UCBC
- Biliary Tract Cancer
- Bladder Cancer
- Brain & Spinal Cord Tumors
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Gastric Tumors
- Head & Neck Cancer
- Leukemia
- Kidney Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neuroendocrine Tumors
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Sarcoma Tumors
- Solid Tumors
- Uterine Cancer
